AI Assistant
Blog
Pricing
Log In
Sign Up
040. Leflunomide as a DMARD in JIA: efficacy and tolerability based on a minimum of three year follow up data
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.